Treating cancer with genetically engineered T cells

This publication has 64 references indexed in Scilit:

• CARs on Track in the Clinic
  Molecular Therapy, 2011
• T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
  Molecular Therapy, 2011
• Of Mice, Not Men: No Evidence for Graft-versus-Host Disease in Humans Receiving T-Cell Receptor–Transduced Autologous T Cells
  Molecular Therapy, 2010
• Advances in the Field of Lentivector-based Transduction of T and B Lymphocytes for Gene Therapy
  Molecular Therapy, 2010
• Enhanced receptor expression and in vitro effector function of a murine-human hybrid MART-1-reactive T cell receptor following a rapid expansion
  Cancer Immunology, Immunotherapy, 2010
• Treatment of Chronic Lymphocytic Leukemia With Genetically Targeted Autologous T Cells: Case Report of an Unforeseen Adverse Event in a Phase I Clinical Trial
  Molecular Therapy, 2010
• Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
  Molecular Therapy, 2010
• A Transposon and Transposase System for Human Application
  Molecular Therapy, 2010
• Adoptive T cell therapy of cancer
  Current Opinion in Immunology, 2010
• Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor
  Nature Medicine, 2008